REFRACTORY SKIN SQUAMOUS CELL CARCINOMA

Clinical trials for REFRACTORY SKIN SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY SKIN SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for REFRACTORY SKIN SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Virus + drug combo tested for Tough-to-Treat skin cancers

Disease control Ongoing

This study is testing a two-part treatment for patients with advanced skin cancers or rare lymphomas that have not responded to other therapies. First, a modified virus is injected directly into tumors to help the immune system recognize cancer. Then, an immunotherapy drug is giv…

Matched conditions: REFRACTORY SKIN SQUAMOUS CELL CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 24, 2026 12:03 UTC

REFRACTORY SKIN SQUAMOUS CELL CARCINOMA

Get alerted when new REFRACTORY SKIN SQUAMOUS CELL CARCINOMA trials appear

Virus + drug combo tested for Tough-to-Treat skin cancers